Denali Therapeutics Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Denali Therapeutics Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2015 to Q4 2023.
  • Denali Therapeutics Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $26.2M, a 35.1% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $26.2M +$6.8M +35.1% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $19.4M +$5.67M +41.4% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $13.7M +$5.56M +68.3% Dec 31, 2021 10-K 2024-02-28
Q4 2020 $8.14M +$2.84M +53.6% Dec 31, 2020 10-K 2024-02-28
Q4 2019 $5.3M +$2.66M +101% Dec 31, 2019 10-K 2023-02-27
Q4 2018 $2.64M +$1.5M +131% Dec 31, 2018 10-K 2022-02-28
Q4 2017 $1.15M +$615K +116% Dec 31, 2017 10-K 2021-02-26
Q4 2016 $531K +$409K +335% Dec 31, 2016 10-K 2020-02-27
Q4 2015 $122K Dec 31, 2015 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.